Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Biosergen AB

BIOSGN.ST

HealthcareSTOSE

SEK 8.40

+SEK 0.30 (+3.70%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

BIOSGN.ST

1Y+0.6 (+7.41%)

Candles, volume, SMA 20, and SMA 50

O 8.4H 8.7L 8.4C 8.7Date Jun 10

BIOSGN.ST

SMA 20 SMA 50 Vol 1.87K

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Biosergen AB is a biopharmaceutical company specializing in the creation of antifungal medications. Its key development initiative is BSG005, an experimental antifungal drug candidate engineered to treat critical invasive fungal infections. The firm was established in 2004 and operates from its headquarters located in Solna, Sweden.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$19.73M

Volume?1.81K

Avg Volume?3.35K

52w RangeSEK 8.10 - SEK 66.00

Beta?-0.04

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide